Find News

Filter articles

Applied Filters

Showing 91 to 100 of 127 results

Pfizer’s Hospira buyout approved in Australia and Canada

Australia, Canada18-08-2015

Pfizer’s $17 billion buyout of Hospira has been approved in Canada and Australia after the countries’ competition bureaus approved the deal.

Pharma patent filings peaked sharply in 2014, report shows

China, International, US04-08-2015

Worldwide applications for pharmaceutical patents “peaked sharply” in 2014, reaching around 28,000, a report has shown.

Biosimilars market value could triple by 2020, says report


The market value for biosimilars around the world could reach $20 billion by the end this year and that figure could nearly triple by 2020, according to a report.

Novartis and Philips talk patents and innovation at Thomson Reuters event


At a Thomson Reuters event in Paris on Thursday to celebrate the European companies featured on its list of top 100 global innovators, panellists including Novartis and Philips discussed the nature of innovation and how to encourage it.

Market for fighting fake pharma packets to soar in value, report says


The global market for products seeking to tackle counterfeit pharmaceutical and cosmetics packaging will reach more than $80 billion by 2020, according to a report.

SIPO rejects Gilead’s Sovaldi patent application


China’s State Intellectual Property Office has rejected Gilead Sciences’s patent application covering its Sovaldi (sofosbuvir) drug after it was challenged by a non-profit group.

BIO 2015: Australia may block gene patents, suggests NZ lawyer

Australia, Canada, EU, New Zealand18-06-2015

Australia could be going down the road of no longer allowing gene patents, New Zealand-based patent lawyer David Nowak said at the BIO International Convention yesterday.

Australia’s highest court sets date for Myriad hearing


The High Court of Australia has revealed it will hear oral arguments in the patent dispute between breast cancer survivor Yvonne D’Arcy and molecular diagnostic company Myriad Genetics on June 16 and 17.

Australia targets reduced drug spending with new reforms


The Australian health minister has revealed a series of reforms that will aim to reduce spending on patented drugs from the pharmaceutical industry.

Gilead faces fresh Sovaldi challenge

Brazil, China, Russia20-05-2015

Gilead Sciences is facing a challenge to its attempt to obtain a patent for its hepatitis C drug Sovaldi in certain Asian, Latin American and European countries.

Showing 91 to 100 of 127 results